These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 32234958)
21. KRas4b-Calmodulin Interaction with Membrane Surfaces: Role of Headgroup, Acyl Chain, and Electrostatics. Shree S; McLean MA; Stephen AG; Sligar SG Biochemistry; 2024 Nov; 63(21):2740-2749. PubMed ID: 39382513 [TBL] [Abstract][Full Text] [Related]
22. KRas4B-PDE6δ complex stabilization by small molecules obtained by virtual screening affects Ras signaling in pancreatic cancer. Casique-Aguirre D; Briseño-Díaz P; García-Gutiérrez P; la Rosa CHG; Quintero-Barceinas RS; Rojo-Domínguez A; Vergara I; Medina LA; Correa-Basurto J; Bello M; Hernández-Rivas R; Del RocioThompson-Bonilla M; Vargas M BMC Cancer; 2018 Dec; 18(1):1299. PubMed ID: 30594165 [TBL] [Abstract][Full Text] [Related]
23. The G protein-coupled receptor GPR31 promotes membrane association of KRAS. Fehrenbacher N; Tojal da Silva I; Ramirez C; Zhou Y; Cho KJ; Kuchay S; Shi J; Thomas S; Pagano M; Hancock JF; Bar-Sagi D; Philips MR J Cell Biol; 2017 Aug; 216(8):2329-2338. PubMed ID: 28619714 [TBL] [Abstract][Full Text] [Related]
24. Is Nanoclustering essential for all oncogenic KRas pathways? Can it explain why wild-type KRas can inhibit its oncogenic variant? Nussinov R; Tsai CJ; Jang H Semin Cancer Biol; 2019 Feb; 54():114-120. PubMed ID: 29307569 [TBL] [Abstract][Full Text] [Related]
25. The hypervariable region of K-Ras4B is responsible for its specific interactions with calmodulin. Abraham SJ; Nolet RP; Calvert RJ; Anderson LM; Gaponenko V Biochemistry; 2009 Aug; 48(32):7575-83. PubMed ID: 19583261 [TBL] [Abstract][Full Text] [Related]
26. Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein. Agamasu C; Frank P; Perkins S; Waybright T; Messing S; Gillette W; Stephen AG J Vis Exp; 2020 Jan; (155):. PubMed ID: 32009649 [TBL] [Abstract][Full Text] [Related]
27. The Key Role of Calmodulin in KRAS-Driven Adenocarcinomas. Nussinov R; Muratcioglu S; Tsai CJ; Jang H; Gursoy A; Keskin O Mol Cancer Res; 2015 Sep; 13(9):1265-73. PubMed ID: 26085527 [TBL] [Abstract][Full Text] [Related]
28. RAS G-domains allosterically contribute to the recognition of lipid headgroups and acyl chains. Arora N; Mu H; Liang H; Zhao W; Zhou Y J Cell Biol; 2024 May; 223(5):. PubMed ID: 38334958 [TBL] [Abstract][Full Text] [Related]
29. Calmodulin extracts the Ras family protein RalA from lipid bilayers by engagement with two membrane-targeting motifs. Chamberlain SG; Gohlke A; Shafiq A; Squires IJ; Owen D; Mott HR Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34480001 [TBL] [Abstract][Full Text] [Related]
30. Molecular mechanism of the association and dissociation of Deltarasin from the heterodimeric KRas4B-PDEδ complex. Bello M; Correa-Basurto J; Vargas-Mejía MÁ Biopolymers; 2019 Nov; 110(11):e23333. PubMed ID: 31568570 [TBL] [Abstract][Full Text] [Related]
31. K-Ras4B/calmodulin/PI3Kα: A promising new adenocarcinoma-specific drug target? Nussinov R; Muratcioglu S; Tsai CJ; Jang H; Gursoy A; Keskin O Expert Opin Ther Targets; 2016 Jul; 20(7):831-42. PubMed ID: 26873344 [TBL] [Abstract][Full Text] [Related]
32. Lu H; Hu Z; Faraudo J; Martí J Nanoscale; 2023 Dec; 15(47):19359-19368. PubMed ID: 38014474 [TBL] [Abstract][Full Text] [Related]
33. Structural analysis of a calmodulin variant from rice: the C-terminal extension of OsCaM61 regulates its calcium binding and enzyme activation properties. Jamshidiha M; Ishida H; Sutherland C; Gifford JL; Walsh MP; Vogel HJ J Biol Chem; 2013 Nov; 288(44):32036-49. PubMed ID: 24052265 [TBL] [Abstract][Full Text] [Related]
34. Direct visualization of interaction between calmodulin and connexin45. Zou J; Salarian M; Chen Y; Zhuo Y; Brown NE; Hepler JR; Yang JJ Biochem J; 2017 Nov; 474(24):4035-4051. PubMed ID: 28963343 [TBL] [Abstract][Full Text] [Related]
35. Interaction of KRas4b with anionic membranes: A special role for PIP Gregory MC; McLean MA; Sligar SG Biochem Biophys Res Commun; 2017 May; 487(2):351-355. PubMed ID: 28412347 [TBL] [Abstract][Full Text] [Related]
36. The quaternary assembly of KRas4B with Raf-1 at the membrane. Jang H; Zhang M; Nussinov R Comput Struct Biotechnol J; 2020; 18():737-748. PubMed ID: 32257057 [TBL] [Abstract][Full Text] [Related]
37. S-Acylation and plasma membrane targeting of the farnesylated carboxyl-terminal peptide of N-ras in mammalian fibroblasts. Schroeder H; Leventis R; Rex S; Schelhaas M; Nägele E; Waldmann H; Silvius JR Biochemistry; 1997 Oct; 36(42):13102-9. PubMed ID: 9335573 [TBL] [Abstract][Full Text] [Related]
38. Quantitative biophysical analysis defines key components modulating recruitment of the GTPase KRAS to the plasma membrane. Lakshman B; Messing S; Schmid EM; Clogston JD; Gillette WK; Esposito D; Kessing B; Fletcher DA; Nissley DV; McCormick F; Stephen AG; Jean-Francois FL J Biol Chem; 2019 Feb; 294(6):2193-2207. PubMed ID: 30559287 [TBL] [Abstract][Full Text] [Related]
39. Conserved allosteric perturbation of the GTPase domains by region 1 of Ras hypervariable regions. Gu X; Zhang Y; Long D Biophys J; 2024 Apr; 123(7):839-846. PubMed ID: 38419331 [TBL] [Abstract][Full Text] [Related]